Dan G. Duda

Company: Massachusetts General Hospital

Job title: Director of Translational Research in GI Radiation Oncology and Investigator; Associate Professor of Tumor Biology

Seminars:

Combining p53 mRNA Nanotherapy with Immune Checkpoint Blockade for Liver Cancer 4:15 pm

Outlining how immunotherapy with immune checkpoint blockade (ICB) shows limited benefits in hepatocellular carcinoma (HCC) and other cancers, mediated in part by the immunosuppressive tumour microenvironment (TME) Examining the effects of restoring p53 expression on the immune TME and ICB efficacy Inducing p53 expression in HCC models effectively, eliciting a global reprogramming of cellular and…Read more

day: Conference Day Two - PM